Literature DB >> 12860342

Gender differences and sex-specific manifestations associated with human immunodeficiency virus infection in women.

Jacob Gilad1, Asnat Walfisch, Abraham Borer, Francisc Schlaeffer.   

Abstract

The rapidly growing rates of human immunodeficiency virus (HIV) infection among women has prompted many challenging issues related to the management and consequences of HIV and its complications in this population. This paper reviews the current evidence with regard to various aspects of HIV infection in women. Special emphasis is placed on gender-differences as well as sex-specific manifestation of this disease, including epidemiology, viral load determination and disease progression, related morbidity, and anti-retroviral therapy. It is concluded that current advances in the understanding of HIV infection among women may lead to further refinement and optimization efforts in the management of HIV-infected women.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860342     DOI: 10.1016/s0301-2115(03)00048-4

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling.

Authors:  Sheila M Adams; Marina V Aksenova; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  Synapse       Date:  2010-11       Impact factor: 2.562

Review 2.  Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches.

Authors:  Jose A Moran; Shireen R Turner; Matthew D Marsden
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

3.  [Correlation between clinical apparatus-based differential diagnosis and neuropathological diagnosis in patients with AIDS].

Authors:  E Akova-Oztürk; S Evers; R Colak-Ekici; C Heese; C H Rickert; D Reichelt; I W Husstedt
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

4.  Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity.

Authors:  Obiamiwe C Umeh; Judith S Currier
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.663

5.  beta-Estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBL.

Authors:  Mingjie Zhang; Qingsheng Huang; Yong Huang; Owen Wood; Weishi Yuan; Caren Chancey; Sylvester Daniel; Maria Rios; Indira Hewlett; Kathleen A Clouse; Andrew I Dayton
Journal:  Retrovirology       Date:  2008-09-22       Impact factor: 4.602

6.  Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection.

Authors:  Marta Rodriguez-Garcia; Nabanita Biswas; Mickey V Patel; Fiona D Barr; Sarah G Crist; Christina Ochsenbauer; John V Fahey; Charles R Wira
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.